🇺🇸 FDA
Pipeline program

TAMOXENE 20 mg compresse rivestite con film

CRCFC-TAMOXI063

Phase 2 small_molecule active

Quick answer

TAMOXENE 20 mg compresse rivestite con film for cystic fibrosis is a Phase 2 program (small_molecule) at Verona Pharma Ireland Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Verona Pharma Ireland Limited
Indication
cystic fibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials